TGTX Average Receivables from 2010 to 2024
| TGTX Stock | USD 13.66 0.34 2.55% |
Average Receivables | First Reported 2010-12-31 | Previous Quarter 155.2 K | Current Value 127.6 K | Quarterly Volatility 57.2 K |
Check TG Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among TGTX main balance sheet or income statement drivers, such as Depreciation And Amortization of 433.5 K, Interest Expense of 13.2 M or Total Revenue of 245.3 M, as well as many exotic indicators such as Price To Sales Ratio of 9.86, Dividend Yield of 4.0E-4 or PTB Ratio of 15.86. TGTX financial statements analysis is a perfect complement when working with TG Therapeutics Valuation or Volatility modules.
TGTX | Average Receivables |
Latest TG Therapeutics' Average Receivables Growth Pattern
Below is the plot of the Average Receivables of TG Therapeutics over the last few years. It is TG Therapeutics' Average Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in TG Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Average Receivables | 10 Years Trend |
|
Average Receivables |
| Timeline |
TGTX Average Receivables Regression Statistics
| Arithmetic Mean | 121,024 | |
| Geometric Mean | 97,520 | |
| Coefficient Of Variation | 47.26 | |
| Mean Deviation | 37,275 | |
| Median | 134,936 | |
| Standard Deviation | 57,195 | |
| Sample Variance | 3.3B | |
| Range | 232.9K | |
| R-Value | 0.19 | |
| Mean Square Error | 3.4B | |
| R-Squared | 0.04 | |
| Significance | 0.49 | |
| Slope | 2,470 | |
| Total Sum of Squares | 45.8B |
TGTX Average Receivables History
About TG Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include TG Therapeutics income statement, its balance sheet, and the statement of cash flows. TG Therapeutics investors use historical funamental indicators, such as TG Therapeutics's Average Receivables, to determine how well the company is positioned to perform in the future. Although TG Therapeutics investors may use each financial statement separately, they are all related. The changes in TG Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on TG Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on TG Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in TG Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Average Receivables | 155.2 K | 127.6 K |
TG Therapeutics Investors Sentiment
The influence of TG Therapeutics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in TGTX. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to TG Therapeutics' public news can be used to forecast risks associated with an investment in TGTX. The trend in average sentiment can be used to explain how an investor holding TGTX can time the market purely based on public headlines and social activities around TG Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
TG Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for TG Therapeutics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average TG Therapeutics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on TG Therapeutics.
TG Therapeutics Implied Volatility | 206.69 |
TG Therapeutics' implied volatility exposes the market's sentiment of TG Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if TG Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that TG Therapeutics stock will not fluctuate a lot when TG Therapeutics' options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards TG Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, TG Therapeutics' short interest history, or implied volatility extrapolated from TG Therapeutics options trading.
Currently Active Assets on Macroaxis
When determining whether TG Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TG Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tg Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tg Therapeutics Stock:Check out the analysis of TG Therapeutics Correlation against competitors. For more information on how to buy TGTX Stock please use our How to Invest in TG Therapeutics guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Complementary Tools for TGTX Stock analysis
When running TG Therapeutics' price analysis, check to measure TG Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TG Therapeutics is operating at the current time. Most of TG Therapeutics' value examination focuses on studying past and present price action to predict the probability of TG Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TG Therapeutics' price. Additionally, you may evaluate how the addition of TG Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |
Is TG Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TG Therapeutics. If investors know TGTX will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TG Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.09 | Revenue Per Share 1.646 | Quarterly Revenue Growth 548.638 | Return On Assets 0.0493 | Return On Equity 0.1157 |
The market value of TG Therapeutics is measured differently than its book value, which is the value of TGTX that is recorded on the company's balance sheet. Investors also form their own opinion of TG Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is TG Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TG Therapeutics' market value can be influenced by many factors that don't directly affect TG Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TG Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if TG Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TG Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.